Search tips
Search criteria 


Logo of narLink to Publisher's site
Nucleic Acids Res. 1996 March 1; 24(5): 885–889.
PMCID: PMC145733

In vitro detection of endonuclease IV-specific DNA damage formed by bleomycin in vivo.


Endonuclease IV of Escherichia coli has been implicated by genetic studies in the repair of DNA damage caused by the antitumor drug bleomycin, but the lesion(s) recognized by this enzyme in vivo have not been identified. We used the sensitive primer activation assay, which monitors the formation of 3'-OH groups that support in vitro synthesis by E.coli DNA polymerase I, to determine whether endonuclease IV-specific damage could be detected in the chromosomal DNA of cells lacking the enzyme after in vivo treatment with bleomycin. Chromosomal DNA isolated after a 1 h bleomycin treatment from wild-type, endonuclease IV-deficient (nfo-) and endonuclease IV-overproducing (p-nfo; approximately 10-fold) strains all supported modest polymerase activity. However, in vitro treatment with purified endonuclease IV activated subsequent DNA synthesis with samples from the nfo- strain (an average of 2.6-fold), to a lesser extent for samples from wild-type cells (2.1-fold), and still less for the p-nfo samples (1.5-fold). This pattern is consistent with the presence of unrepaired damage that correlates inversely with the in vivo activity of endonuclease IV. Incubation of the DNA from bleomycin-treated nfo- cells with polymerase and dideoxynucleoside triphosphates lowered the endonuclease IV-independent priming activity, but did not affect the amount of activation seen after endonuclease IV treatment. Primer activation with DNA from the nfo- strain could also be obtained with purified E.coli exonuclease III in vitro, but a quantitative comparison demonstrated that endonuclease IV was > or = 5-fold more active in this assay. Thus, endonuclease IV-specific damage can be detected after in vivo exposure to bleomycin. These may be 2-deoxy-pentos-4-ulose residues, but other possibilities are discussed.

Full Text

The Full Text of this article is available as a PDF (71K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Umezawa H. Microbial secondary metabolites with potential use in cancer treatment. (Plasmid involvement in biosynthesis and compounds. Biomedicine. 1977 Jul;26(4):236–249. [PubMed]
  • Müller WE, Zahn RK. Bleomycin, an antibiotic that removes thymine from double-stranded DNA. Prog Nucleic Acid Res Mol Biol. 1977;20:21–57. [PubMed]
  • Giloni L, Takeshita M, Johnson F, Iden C, Grollman AP. Bleomycin-induced strand-scission of DNA. Mechanism of deoxyribose cleavage. J Biol Chem. 1981 Aug 25;256(16):8608–8615. [PubMed]
  • Henner WD, Rodriguez LO, Hecht SM, Haseltine WA. gamma Ray induced deoxyribonucleic acid strand breaks. 3' Glycolate termini. J Biol Chem. 1983 Jan 25;258(2):711–713. [PubMed]
  • Murugesan N, Xu C, Ehrenfeld GM, Sugiyama H, Kilkuskie RE, Rodriguez LO, Chang LH, Hecht SM. Analysis of products formed during bleomycin-mediated DNA degradation. Biochemistry. 1985 Oct 8;24(21):5735–5744. [PubMed]
  • Demple B, Johnson A, Fung D. Exonuclease III and endonuclease IV remove 3' blocks from DNA synthesis primers in H2O2-damaged Escherichia coli. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7731–7735. [PubMed]
  • Levin JD, Johnson AW, Demple B. Homogeneous Escherichia coli endonuclease IV. Characterization of an enzyme that recognizes oxidative damage in DNA. J Biol Chem. 1988 Jun 15;263(17):8066–8071. [PubMed]
  • Levin JD, Demple B. Analysis of class II (hydrolytic) and class I (beta-lyase) apurinic/apyrimidinic endonucleases with a synthetic DNA substrate. Nucleic Acids Res. 1990 Sep 11;18(17):5069–5075. [PMC free article] [PubMed]
  • Greenberg JT, Monach P, Chou JH, Josephy PD, Demple B. Positive control of a global antioxidant defense regulon activated by superoxide-generating agents in Escherichia coli. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6181–6185. [PubMed]
  • Tsaneva IR, Weiss B. soxR, a locus governing a superoxide response regulon in Escherichia coli K-12. J Bacteriol. 1990 Aug;172(8):4197–4205. [PMC free article] [PubMed]
  • Cunningham RP, Saporito SM, Spitzer SG, Weiss B. Endonuclease IV (nfo) mutant of Escherichia coli. J Bacteriol. 1986 Dec;168(3):1120–1127. [PMC free article] [PubMed]
  • Nunoshiba T, deRojas-Walker T, Wishnok JS, Tannenbaum SR, Demple B. Activation by nitric oxide of an oxidative-stress response that defends Escherichia coli against activated macrophages. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9993–9997. [PubMed]
  • Povirk LF, Houlgrave CW. Effect of apurinic/apyrimidinic endonucleases and polyamines on DNA treated with bleomycin and neocarzinostatin: specific formation and cleavage of closely opposed lesions in complementary strands. Biochemistry. 1988 May 17;27(10):3850–3857. [PubMed]
  • Häring M, Rüdiger H, Demple B, Boiteux S, Epe B. Recognition of oxidized abasic sites by repair endonucleases. Nucleic Acids Res. 1994 Jun 11;22(11):2010–2015. [PMC free article] [PubMed]
  • Hagensee ME, Moses RE. Bleomycin-treated DNA is specifically cleaved only by endonuclease IV in E. coli. Biochim Biophys Acta. 1990 Jan 30;1048(1):19–23. [PubMed]
  • Saporito SM, Cunningham RP. Nucleotide sequence of the nfo gene of Escherichia coli K-12. J Bacteriol. 1988 Nov;170(11):5141–5145. [PMC free article] [PubMed]
  • Ramotar D, Popoff SC, Demple B. Complementation of DNA repair-deficient Escherichia coli by the yeast Apn1 apurinic/apyrimidinic endonuclease gene. Mol Microbiol. 1991 Jan;5(1):149–155. [PubMed]
  • Takeuchi M, Lillis R, Demple B, Takeshita M. Interactions of Escherichia coli endonuclease IV and exonuclease III with abasic sites in DNA. J Biol Chem. 1994 Aug 26;269(34):21907–21914. [PubMed]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press